Haleon PLC Holding(s) in Company (2052A)
18 Gennaio 2024 - 6:00PM
UK Regulatory
TIDMHLN TIDMGSK
RNS Number : 2052A
Haleon PLC
18 January 2024
18 January 2024
HALEON PLC
("Haleon" or "the Company")
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BMX86B70
Issuer Name
HALEON PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
GSK plc
City of registered office (if applicable)
BRENTFORD
Country of registered office (if applicable)
United Kingdom
Name City of registered office Country of registered office
GSK (No.1) Scottish Limited Partnership Edinburgh Scotland
=========================== ==============================
GSK LP Limited London England
=========================== ==============================
GSK GP 1 Limited Edinburgh Scotland
=========================== ==============================
4. Details of the shareholder
Name City of registered office Country of registered office
Vidacos Nominees Limited London England
=========================== ==============================
5. Date on which the threshold was crossed or reached
17-Jan-2024
6. Date on which Issuer notified
18-Jan-2024
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 4.170000 0.000000 4.170000 385320110
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 7.420000 0.000000 7.420000
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB00BMX86B70 0 385320110 0.000000 4.170000
====================== ====================== ====================== ======================
Sub Total 8.A 385320110 4.170000%
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Sub Total 8.B2
========================================================= =================== ==================
9. Information in relation to the person subject to the
notification obligation
2. Full chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is through financial equals or is higher
higher than the instruments if it than the notifiable
notifiable threshold equals or is higher threshold
than the notifiable
threshold
GSK plc (Chain 1) 2.850000 2.850000%
===================== ===================== ======================
GlaxoSmithKline
Holdings Limited
GSK plc (Chain 1) (Chain 1) 2.850000 2.850000%
======================= ===================== ===================== ======================
GlaxoSmithKline
Finance plc (Chain
GSK plc (Chain 1) 1) 2.850000 2.850000%
======================= ===================== ===================== ======================
Glaxo Group Limited
GSK plc (Chain 1) (Chain 1) 2.850000 2.850000%
======================= ===================== ===================== ======================
GSK plc (Chain 2) 1.330000 1.330000%
===================== ===================== ======================
GSK LP Limited
GSK plc (Chain 2) (Chain 2) 1.330000 1.330000%
======================= ===================== ===================== ======================
GSK GP 1 Limited
GSK plc (Chain 2) (Chain 2) 1.330000 1.330000%
======================= ===================== ===================== ======================
GSK (No. 1) Scottish
Limited Partnership
GSK plc (Chain 2) (Chain 2) 1.330000 1.330000%
======================= ===================== ===================== ======================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
GSK plc is making this notification on behalf of itself and on
behalf of GSK LP Limited, GSK GP 1 Limited and GSK (No.1) Scottish
Limited Partnership.
This notification relates to the sale by GSK (No.1) Scottish
Limited Partnership (an entity indirectly wholly-owned by GSK plc)
of a portion of its interest in Haleon plc.
GSK GP 1 Limited is the sole general partner of GSK (No.1)
Scottish Limited Partnership. GSK LP Limited is the sole limited
partner of GSK (No.1) Scottish Limited Partnership.
Glaxo Group Limited and GSK (No.1) Scottish Limited Partnership
hold their shares in Haleon plc via a custodian, Vidacos Nominees
Limited, which holds the legal title to those shares on their
behalf pursuant to a custody arrangement.
12. Date of Completion
18-Jan-2024
13. Place Of Completion
London, England
Amanda Mellor, Company Secretary
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUWVNRSNUAAAR
(END) Dow Jones Newswires
January 18, 2024 12:00 ET (17:00 GMT)
Grafico Azioni Haleon (LSE:HLN)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Haleon (LSE:HLN)
Storico
Da Mag 2023 a Mag 2024